Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-upVaccine, 2005
- Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese ChildrenInfection and Immunity, 2004
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Vi-deficient and nonfimbriated mutants ofSalmonella typhiagglutinate human blood type antigens and are hyperinvasiveFEMS Microbiology Letters, 1998
- Comparison of ViaB regions of Vi-positive organismsFEMS Microbiology Letters, 1997
- Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigenMicrobiology, 1995
- The Vi antigen of Salmonella typhi: molecular analysis of the viaB locusJournal of General Microbiology, 1992
- Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.Journal of Experimental Medicine, 1987
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987
- Mechanism of the Protective Action of Anti-Salmonella IgM in Experimental Mouse SalmonellosisMicrobiology, 1984